drugset / Trial / NCT06063109
A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.
RandomizedParallel-groupOpen-labelTreatment
Summary
The study was designed to evaluate the safety and pharmacokinetic interaction between THP-00101 and THP-00102 in healthy adult volunteers.
Timeline
- Start
- 2023-10-09
- Primary completion
- 2023-11-09
- Completion
- 2023-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 80 mg | Oral |